Monday, November 16, 2026

Toxic Economy: Common Chemicals Cost US Billions Every Year

Researchers estimate the United States economy takes a $340 billion hit annually as endocrine-disrupting compounds lower IQs, increase behavior problems and exacerbate health woes like obesity and diabetes.

Reducing climate change will prevent future deadly epidemics says new study

"Recent outbreaks of animal-borne emerging infectious diseases have likely been precipitated by a complex interplay of changing ecological, epidemiological and socio-economic factors."

Babies poop has ten times more microplastics than in adults, study finds

“Unfortunately, with the modern lifestyle, babies are exposed to so many different things for which we don't know what kind of effect they can have later in their life.”

We’ve breached Earth’s threshold for chemical pollution, study says

Many thousands of human-made chemicals and synthetic pollutants are circulating throughout our world, with new ones entering production all the time —...

Renewable energy isn’t perfect, but it’s far better than fossil fuels

Any real comparison between oil sands and lithium batteries shows that oil sands products, from extracting and processing to transporting and burning, are by far the most destructive.

Israeli siege leaves 130,000 children trapped and facing starvation in Northern Gaza

130,000 children under 10 face starvation and dire conditions as aid remains blocked in northern Gaza.

High-tech workplace surveillance: New report warns of dystopian mass surveillance amid COVID-19

“The speed at which these new privacy-shredding technologies have been unleashed is alarming, especially given that none of them have been proven to be effective at mitigating the spread of COVID-19.”

Congress: Demand White House transcript

Only Congress, Republicans and Democrats acting together, can protect the nation from this incompetent, venal, and dangerous executive.

The persistence of ‘Israel First’

Trump’s Middle East record reveals the short life of “America First.”

Psychedelic drug in clinical trial to help stroke victims recover by rewiring brain

Algernon Pharmaceuticals, a Canadian-based company, began its study this week in which stroke participants will be given a microdose of DMT with the hope of minimizing damage and maximizing recovery.